Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.

doi:10.3389/fimmu.2021.689966

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.

Frontiers in immunology - 1 Jan 2021

Torres-Ruiz Jiram, Pérez-Fragoso Alfredo, Maravillas-Montero José Luis, Llorente Luis, Mejía-Domínguez Nancy R, Páez-Franco José Carlos, Romero-Ramírez Sandra, Sosa-Hernández Victor Andrés, Cervantes-Díaz Rodrigo, Absalón-Aguilar Abdiel, Nuñez-Aguirre Miroslava, Juárez-Vega Guillermo, Meza-Sánchez David, Kleinberg-Bid Ari, Hernández-Gilsoul Thierry, Ponce-de-León Alfredo, Gómez-Martín Diana

Abstract excerpt

Background: Most of the explanatory and prognostic models of COVID-19 lack of a comprehensive assessment of the wide COVID-19 spectrum of abnormalities. The aim of this study was to unveil novel biological features to explain COVID-19 severity and prognosis (death and disease progression). Methods: A predictive model for COVID-19 severity in 121 patients was constructed by ordinal logistic regression calculating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Extracellular Traps

Share to Hemoglobins

Share to Metabolome

Share to Muscular Atrophy

Share to Neutrophils

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 34566957
DOI: 10.3389/fimmu.2021.689966
PMCID: PMC8456081

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.PMID 34566957Read ↗

COVID-19 severity is associated with immunopathology and multi-organ damageSemantic proximity Read ↗

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeSemantic proximity Read ↗

Correlating COVID-19 severity with biomarker profiles and patient prognosisSemantic proximity Read ↗

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read ↗

Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19Semantic proximity Read ↗

Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID.Semantic proximity Read ↗

Integrative Transcriptomic Profiling of NK Cells and Monocytes: Advancing Diagnostic and Therapeutic Strategies for COVID-19Semantic proximity Read ↗

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Semantic proximity Read ↗

Complex patterns of multimorbidity associated with severe COVID-19 and Long COVIDSemantic proximity Read ↗

Metabolic predictors of COVID-19 mortality and severity: A Survival AnalysisSemantic proximity Read ↗

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read ↗

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.